Comment on “Effects of liraglutide treatment for 18 days on metabolic parameters, regional body composition and the myostatin–activin–follistatin– IGF ‐1 axis”

Documenti analoghi

• Effects of liraglutide treatment for 18 days on metabolic parameters, regional body composition and the myostatin–activin–follistatin– IGF ‐1 axis: Results from an exploratory, randomized, placebo‐controlled, crossover study
  di: Valeria Gutierrez de Piñeres, et al.
  Pubblicazione: (2025)
• Rapid improvement of renal microcirculatory homeostasis by liraglutide following diabetes induction
  di: Yuan Li, et al.
  Pubblicazione: (2026)
• Mental health changes after 4 months of weight loss treatment with the glucagon‐like peptide‐1 analogue liraglutide 3.0 mg
  di: Susanne Kuckuck, et al.
  Pubblicazione: (2026)
• Adipocyte‐specific IGF1R knockout activates the β‐catenin/apelin axis to combat diet‐induced obesity in male mice
  di: Haoan Wang, et al.
  Pubblicazione: (2025)
• Adherence to liraglutide among individuals with overweight and obesity: Patient characteristics and clinical measures
  di: Amit Guy, et al.
  Pubblicazione: (2024)